J. Hillert

Increased Soluble 4‐1BB Ligand (4‐1BBL) Levels in Peripheral Blood of Patients with Multiple Sclerosis

K. Kostulas, J. Hillert, V. Karrenbauer, 2006, Scandinavian journal of immunology.

Neutralising antibodies to interferon β in multiple sclerosis

E. Havrdová, M. Comabella, J. Killestein, 2007, Journal of Neurology.

Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity

M. Suoniemi, J. Hillert, A. Fogdell-Hahn, 2007, Multiple sclerosis.

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.

L. Kappos, C. Polman, H. Hartung, 2007, Journal of neurology.

Impression of Clinical Worsening Fails to Predict Interferon-β Neutralizing Antibody Status

J. Hillert, A. Fogdell-Hahn, U. Rot, 2008, The Journal of international medical research.

Anti-Natalizumab Antibodies in Patients with Multiple Sclerosis

M. Lundkvist, A. Fogdell-Hahn, E. Engdahl, 2012 .

Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta

M. Lundkvist, A. Fogdell-Hahn, Eva Greiner, 2010, Multiple sclerosis.